Parameters affecting in-liquid drying microencapsulation and release rate of cefaclor

被引:11
作者
Chow, AHL [1 ]
Ho, SSS [1 ]
Tong, HHY [1 ]
Ma, HHM [1 ]
机构
[1] Chinese Univ Hong Kong, Fac Med, Dept Pharm, Shatin, NT, Peoples R China
关键词
in-liquid drying microencapsulation; drug-polymer ratio; stirring speed; cefaclor-ethylcellulose microspheres; sustained release;
D O I
10.1016/S0378-5173(98)00199-9
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
An in-liquid drying microencapsulation method for producing sustained release cefaclor (CF) microspheres has been developed. Sieved fractions of CF monohydrate particles together with polyvinylpyrrolidone (M-w similar to 40 000) were dispersed in a solvent mixture of dichloromethane with cyclohexane (40:60 v/v) containing dissolved ethylcellulose (EC; 48-49.5% ethoxy content). Encapsulation was effected by adding the dispersion to a stirred aqueous medium saturated with CF. The resulting microspheres (collected overnight and oven-dried at 40 degrees C) were examined for size and surface features by scanning electron microscopy, and for solid-state interactions and phase changes using differential scanning calorimetry (DSC), thermogravimetric analysis and powder X-ray diffractometry. The rate and extent of CF release in aqueous medium was measured at 37 degrees C using the USP rotating basket method at 100 rpm. The size, degree of sphericity, and rate of CF release of the microspheres were all shown to depend on the CF to EC mass ratio and the stirring speed employed in encapsulation. Higher EC to CF mass ratio and lower stirring speed afforded microspheres with slower release rate of CF. The rate of CF release from the microspheres fit the simplified Higuchi's planar model equation, and for the samples prepared at various EC:CF ratios, exhibited a strong correlation with drug loading (r =0.98; n=4 (mean values); p <0.05). DSC studies on the samples indicated an absence of molecular interactions between EC and CF in the microspheres. The results demonstrate that the in-liquid drying method, if appropriately optimized, could be used to produce sustained-release CF microspheres with the desired release pattern and physical properties. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:113 / 125
页数:13
相关论文
共 6 条
[1]
HARVEY SC, 1990, REMINGTONS PHARM SCI, P1163
[3]
HULS CE, 1992, CLIN PHARMACOL THER, P1062
[4]
LORENZ JL, 1980, ANAL PROFILES DRUG S, V9, P107
[5]
Thies C., 1992, MICROCAPSULES NANOPA, P47
[6]
*USP, 1990, USP PHARM, V22, P1578